Related Experiment Video
Updated: May 28, 2026

Glucose-Stimulated Insulin Secretion via Perfusion through the Mice Vasculature with an Intact Pancreas
Published on: July 25, 2025
Preoperative glutamine infusion improves glycemia in heart surgery patients
Miguel Nasser Hissa1, Raquel Cavalcante de Vasconcelos, Sergio Botelho Guimarães
1Walter Cantidio Hospital and Experimental Surgery Research Laboratory (LABCEX), Federal University of Ceara, Fortaleza-CE, Brazil.
Pre-operative L-alanyl-glutamine (L-Ala-Gln) supplementation significantly improved blood glucose control in patients undergoing myocardial revascularization surgery. This dietary intervention demonstrated enhanced glycemic management during the intraoperative period.
Area of Science:
- Cardiology
- Metabolic Medicine
- Surgical Nutrition
Background:
- Coronary artery disease necessitates surgical intervention like myocardial revascularization.
- Maintaining stable blood glucose levels is critical during major surgeries, especially those involving cardiopulmonary bypass.
- The role of nutritional support, such as amino acid supplementation, in perioperative glycemic control requires further investigation.
Purpose of the Study:
- To assess the impact of pre-operative L-alanyl-glutamine (L-Ala-Gln) administration on blood glucose regulation.
- To evaluate glycemic control in patients with coronary artery obstruction undergoing myocardial revascularization.
- To determine if L-Ala-Gln influences intraoperative glycemia in this patient cohort.
Main Methods:
- A randomized controlled trial involving 22 patients undergoing myocardial revascularization.
- Patients received either L-Ala-Gln (20% solution) plus saline or saline alone pre-operatively.
- Blood glucose levels were monitored at multiple time points: pre-operative, intraoperative (before and after extracorporeal perfusion), and post-operative (12 and 24 hours).
Main Results:
- Patients receiving L-Ala-Gln exhibited a significant reduction in blood glucose levels during the intraoperative phase.
- No significant decrease in glycemia was observed in the control group receiving only saline.
- The observed glucose reduction in the L-Ala-Gln group was independent of exogenous insulin administration, suggesting a direct metabolic effect.
Conclusions:
- Pre-operative L-alanyl-glutamine supplementation is effective in improving glycemic control for patients with coronary artery occlusion undergoing myocardial revascularization.
- L-Ala-Gln may represent a valuable nutritional strategy to optimize metabolic status in cardiac surgery patients.
- Further research is warranted to elucidate the precise mechanisms underlying L-Ala-Gln's glucose-lowering effects in this context.
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Kidney Transplant II: Surgical Procedure
Hypoglycemia and Glucagon
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
